Lyra Therapeutics LYRA
LYRA
$0.00 -0.04 (-100.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Prepaid Assets (2019 - 2025)

Lyra Therapeutics (LYRA) recorded quarterly Prepaid Assets of $379000.0 in Q4 2025, down 60.68% on a QoQ basis from $964000.0 in Q3 2025, and down 84.52% YoY from $2.4 million in Q4 2024.

Lyra Therapeutics (LYRA) Prepaid Assets (2019 - 2025) Analysis & Trends

Lyra Therapeutics (LYRA) has reported Prepaid Assets for 7 consecutive years, with $379000.0 the latest figure, recorded in Q4 2025.

  • Prepaid Assets for Q4 2025 came in at $379000.0, down 84.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $379000.0 (down 84.52% YoY), and the FY2025 annual result was $379000.0, down 84.52% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $379000.0, down from $964000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $2.9 million in Q4 2022, with the low at $379000.0 in Q4 2025.
  • A 5-year average of $1.9 million and a median of $2.1 million in 2023 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets jumped 325.26% in 2021 and plunged 84.52% in 2025, its largest moves.
  • Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then soared by 35.19% to $2.9 million in 2022, then declined by 29.54% to $2.1 million in 2023, then grew by 18.38% to $2.4 million in 2024, then sank by 84.52% to $379000.0 in 2025.
  • The last three Prepaid Assets figures came in at $379000.0 (Q4 2025), $964000.0 (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Lyra Therapeutics 70,995.28 70,995.28 -

Historic Data

Download Data
DateValue
Dec 31, 2025 379,000.00
Sep 30, 2025 964,000.00
Jun 30, 2025 1.28 Mn
Mar 31, 2025 2.17 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 2.82 Mn
Jun 30, 2024 1.94 Mn
Mar 31, 2024 2.33 Mn
Dec 31, 2023 2.07 Mn
Sep 30, 2023 2.37 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 2.09 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 2.34 Mn
Jun 30, 2022 1.38 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 2.17 Mn
Sep 30, 2021 2.76 Mn
Jun 30, 2021 1.03 Mn
Mar 31, 2021 1.25 Mn